There are about 2 related results
There are about 2 related results
Siemens Healthineers’ heart surgery robot CorPath GRX gained marketing approval in China
Siemens Healthineers pledged an additional investment of over RMB1 billion (about $142 million) to establish a state-of-the-art research and manufacturing site in Shenzhen
